195 related articles for article (PubMed ID: 30257437)
1. Renal Injury during Long-Term Crizotinib Therapy.
Yasuma T; Kobayashi T; D'Alessandro-Gabazza CN; Fujimoto H; Ito K; Nishii Y; Nishihama K; Baffour Tonto P; Takeshita A; Toda M; Gabazza EC; Taguchi O; Yonemura S; Hataji O
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30257437
[TBL] [Abstract][Full Text] [Related]
2. Crizotinib-Associated Renal Cysts in Anaplastic Lymphoma Kinase-Positive Lung Cancer Patients: A Single-Center Experience.
Eiamprapaporn P; Mungwatthana N; Twinprai P; Sookprasert A; Chindaprasirt J; Ahooja A; Watthanaudomrot S; Sirithanaphol W
Urol Int; 2020; 104(3-4):269-272. PubMed ID: 31480046
[TBL] [Abstract][Full Text] [Related]
3. A Complex Renal Cyst in a Patient on Crizotinib: Case Report.
Liaw CW; Palese M; Fabrizio LD
Urology; 2019 Sep; 131():21-23. PubMed ID: 31078629
[No Abstract] [Full Text] [Related]
4. Complex renal cysts combined with hemorrhage during crizotinib treatment for ALK-rearranged lung adenocarcinoma.
Yang L; Gu J; Niu X
Cancer Treat Res Commun; 2021; 27():100373. PubMed ID: 33865115
[TBL] [Abstract][Full Text] [Related]
5. Regression of Crizotinib-Associated Complex Cystic Lesions after Switching to Alectinib.
Taima K; Tanaka H; Tanaka Y; Itoga M; Takanashi S; Tasaka S
Intern Med; 2017 Sep; 56(17):2321-2324. PubMed ID: 28794366
[TBL] [Abstract][Full Text] [Related]
6. Crizotinib-induced lichenoid drug eruption in a patient with lung cancer.
Ho YH; Chen CL
Cutis; 2018 Dec; 102(6):403-406. PubMed ID: 30657798
[TBL] [Abstract][Full Text] [Related]
7. Crizotinib Associated Renal Cysts [CARCs]: incidence and patterns of evolution.
Cameron LB; Jiang DH; Moodie K; Mitchell C; Solomon B; Parameswaran BK
Cancer Imaging; 2017 Feb; 17(1):7. PubMed ID: 28209203
[TBL] [Abstract][Full Text] [Related]
8. Complex renal cysts associated with crizotinib treatment.
Schnell P; Bartlett CH; Solomon BJ; Tassell V; Shaw AT; de Pas T; Lee SH; Lee GK; Tanaka K; Tan W; Tang Y; Wilner KD; Safferman A; Han JY
Cancer Med; 2015 Jun; 4(6):887-96. PubMed ID: 25756473
[TBL] [Abstract][Full Text] [Related]
9. Development of renal cysts after crizotinib treatment in advanced ALK-positive non-small-cell lung cancer.
Lin YT; Wang YF; Yang JC; Yu CJ; Wu SG; Shih JY; Yang PC
J Thorac Oncol; 2014 Nov; 9(11):1720-5. PubMed ID: 25436806
[TBL] [Abstract][Full Text] [Related]
10. Renal cyst formation in patients treated with crizotinib for non-small cell lung cancer-Incidence, radiological features and clinical characteristics.
Halpenny DF; McEvoy S; Li A; Hayan S; Capanu M; Zheng J; Riely G; Ginsberg MS
Lung Cancer; 2017 Apr; 106():33-36. PubMed ID: 28285691
[TBL] [Abstract][Full Text] [Related]
11. Regression of renal cyst in a NSCLC patient treated with crizotinib.
Okauchi S; Kawai K; Miyazaki K; Yamada H; Satoh H
Adv Respir Med; 2019; 87(3):201-202. PubMed ID: 31282565
[No Abstract] [Full Text] [Related]
12. Development of crizotinib-associated renal cyst in a non-small cell lung cancer patient with ALK fusion: a case report and review of the literature.
Zhang P; Xu J; Wu Q; Qian J; Wang S
Diagn Pathol; 2024 Apr; 19(1):58. PubMed ID: 38616252
[TBL] [Abstract][Full Text] [Related]
13. Crizotinib-associated Renal Cyst Formation in a Pediatric Patient With ALK+ Epithelioid Inflammatory Myofibroblastic Sarcoma.
Kopelevich A; Holzman SA; La J; Lai HA; Torno L; Stephany HA
Urology; 2021 Mar; 149():222-224. PubMed ID: 32882306
[TBL] [Abstract][Full Text] [Related]
14. Infected complex renal cysts during crizotinib therapy in a patient with non-small cell lung cancer positive for ALK rearrangement.
Yoneshima Y; Okamoto I; Arimura-Omori M; Kimura S; Hidaka-Fujimoto N; Iwama E; Harada T; Takayama K; Nakanishi Y
Invest New Drugs; 2015 Apr; 33(2):510-2. PubMed ID: 25433426
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous regression of crizotinib-associated complex renal cysts during continuous crizotinib treatment.
Klempner SJ; Aubin G; Dash A; Ou SH
Oncologist; 2014 Sep; 19(9):1008-10. PubMed ID: 25096999
[TBL] [Abstract][Full Text] [Related]
16. Effects of crizotinib on creatinine clearance and renal hemodynamics.
Meijer-Schaap L; Van Putten JWG; Janssen WMT
Lung Cancer; 2018 Aug; 122():192-194. PubMed ID: 30032830
[TBL] [Abstract][Full Text] [Related]
17. [A case of crizotinib-associated renal cysts].
Quan LL; Huang P; Liang YC; Chen FW; Liu SB; Xin WW
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):356-359. PubMed ID: 38599812
[TBL] [Abstract][Full Text] [Related]
18. The renal effects of ALK inhibitors.
Izzedine H; El-Fekih RK; Perazella MA
Invest New Drugs; 2016 Oct; 34(5):643-9. PubMed ID: 27468827
[TBL] [Abstract][Full Text] [Related]
19. Acute kidney injury following crizotinib administration for non-small-cell lung carcinoma.
Gastaud L; Ambrosetti D; Otto J; Marquette CH; Coutts M; Hofman P; Esnault V; Favre G
Lung Cancer; 2013 Nov; 82(2):362-4. PubMed ID: 24001942
[TBL] [Abstract][Full Text] [Related]
20. Development of Complex Renal Cysts during Crizotinib Treatment and Also during Alectinib Treatment: A Possible Drug Class Effect?
Longo V; Catino AM; Montrone M; Pesola F; Pizzutilo P; Delbene G; Gatti P; Ferrante A; Galetta D
J Thorac Oncol; 2019 Aug; 14(8):e170-e172. PubMed ID: 31345340
[No Abstract] [Full Text] [Related]
[Next] [New Search]